Abstract
Autism is a neurodevelopmental disorder characterized by stereotyped interests and behaviors, and abnormalities in verbal and nonverbal communication. Autism is reported as a multifactorial disorder resulting from interactions between genetic, environmental, and immunological factors. Excitotoxicity and oxidative stress are potential mechanisms, which are likely to serve as a converging point to these risk factors. Numerous studies suggest that excitotoxicity is a likely cause of neuronal dysfunction in autistic patients. Glutamate is the main excitatory neurotransmitter generated in the CNS, and over activation of glutamate receptors triggers excitotoxicity. Hyperactivation of glutamatergic receptors, N-methyl-d-aspartate (NMDA) and 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate (AMPA), leads to activation of enzymes, which damage cellular structure, membrane permeability, and electrochemical gradients. The role of excitotoxicity in autistic subjects is summarized in this chapter.
Abbreviations
- AMPA:
-
2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate
- iNOS:
-
Inducible nitric oxide
- MRI:
-
Magnetic resonance imaging
- NMDA:
-
N-methyl-d-aspartate
- NO•:
-
Nitric oxide
References
Babu, G. N., Bawari, M., & Ali, M. M. (1994). Lipid peroxidation potential and antioxidant status of circumventricular organs of rat brain following neonatal monosodium glutamate. Neurotoxicology, 15, 773–777.
Baron-Cohen, S., Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E., & Brayne, C. (2009). Prevalence of autism-spectrum conditions: UK school-based population study. The British Journal of Psychiatry, 194, 500–509.
Blaylock, R. L. (2003). The central role of excitotoxicity in autism spectrum disorders. The Journal of the American Nutraceutical Association, 6, 7–19.
Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22, 574–579.
Cohly, H. H., & Panja, A. (2005). Immunological findings in autism. International Review of Neurobiology, 71, 317–341.
Ekonomou, A., & Angelatou, F. (1999). Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced “kindling” model of epilepsy. Neurochemical Research, 24, 1515–1522.
Eliasson, M. J., Huang, Z., & Ferrante, R. J. (1999). Neuronal nitric oxide synthease activation and peroxynitrite formation in ischemic stroke linked to neural damage. The Journal of Neuroscience, 19, 59105918.
Espey, M. G., Kustova, Y., Sei, Y., & Basile, A. S. (1998). Extracellular glutamate levels are chronically elevated in the brains of LPBM5-infected mice: A mechanism of retrovirus-induced encephalopathy. Journal of Neurochemistry, 71, 2079–2087.
Farooqui, A. A., & Horrocks, L. A. (1994). Excitotoxicity and neurological disorders: Involvement of membrane phospholipids. International Review of Neurobiology, 36, 267–323.
Fontana, A., Constam, D., Frei, K., et al. (1996). Cytokines and defense against CNS infection. In R. M. Ransohoff & E. N. Beneviste (Eds.), Cytokines and the CNS. CRC Press. ISBN-10: 0849324521.
Fosslier, E. (2001). Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Annals of Clinical and Laboratory Science, 31, 25–67.
Gillberg, C., & Coleman, M. (2000). The biology of autistic syndromes (3rd ed.). Mac Keith. (Distributed by Cambridge University Press) Mac Keith Press.
Gospe, S. M., & Hecht, S. T. (1998). Longitudinal MRI findings in pyridoxine dependent seizures. Neurology, 51, 74–78.
Johnston, M. V. (1995). Neurotransmitters and vulnerability of the developing brain. Brain & Development, 17, 301–306.
Lan, J. Y., Skeberdis, V. A., Jover, T., Grooms, S. Y., Lin, Y., Araneda, R. C., et al. (2001). Protein kinase C modulates NMDA receptor trafficking and gating. Nature Neuroscience, 4, 382–390.
Mathern, G. W., Pretorius, J. K., Mendoza, D., et al. (1999). Hippocampal N-methyl-D-aspartate receptor subunit mRNA levels in temporal lobe epilepsy patients. Annals of Neurology, 46, 343–358.
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988). Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Research, 451, 205–212.
Olney, J. W. (1969). Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science, 165, 719721.
Olney, J. W., Collias, R. C., & Sloviter, R. S. (1986). Excitotoxic mechanism of epileptic brain damage. Advances in Neurology, 44, 857–877.
Page, L. A., Daly, E., Schmitz, N., Simmons, A., Toal, F., Deeley, Q., Ambery, F., McAlonan, G. M., Murphy, K. C., & Murphy, D. G. M. (2006). In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. The American Journal of Psychiatry, 163(12), 2189–2192.
Rogawski, M. A. (1995). Excitatory amino acids and seizures. In T. W. Stone (Ed.), CNS neurotransmitters and neuromodulators: Glutamate (pp. 219–237). CRC Press.
Saitoh, O., Karns, C. M., & Courchesne, E. (2001). Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area cystein in autism. Brain, 124, 1317–1324.
Shinohe, A., Hashimoto, K., Nakamura, K., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 1472–1477.
Zilbovicius, M., Boddaert, N., Belin, P., et al. (2000). Temporal lobe dysfunction in childhood autism: A PET study. The American Journal of Psychiatry, 157, 1988–1993.
Acknowledgments
The work has been partly supported by Sultan Qaboos University Internal grant (Grant # IG/AGR/FOOD/11/02) and the Research Council; Oman (Grant # RC/AGR/FOOD/11/01). This work has been also supported by the Alzheimer’s Association (grant # IIRG- 08-89545) and by the Rebecca Cooper foundation (Australia). Dr Nady Braidy is the recipient of an Alzheimer’s Australia Viertel Foundation Postdoctoral Research Fellowship at the University of New South Wales.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Essa, M.M., Braidy, N., Subash, S., Vijayan, R.K., Guillemin, G.J. (2022). Excitotoxicity in the Pathogenesis of Autism. In: Kostrzewa, R.M. (eds) Handbook of Neurotoxicity. Springer, Cham. https://doi.org/10.1007/978-3-030-71519-9_148-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-71519-9_148-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71519-9
Online ISBN: 978-3-030-71519-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences